Apollo Hospitals Reports Strong Q4 FY26 Earnings

Apollo Hospitals Enterprises Ltd announced its Q4 FY26 financial results, showing significant year-over-year growth. Consolidated revenue for the quarter reached ₹66,055 million, an 18% increase from the previous year. Consolidated EBITDA grew 31% to ₹10,109 million. Profit After Tax (PAT) saw a substantial jump of 36%, amounting to ₹5,292 million.

For the full fiscal year FY26, consolidated revenue was ₹252,285 million, up 16% year-over-year, and PAT grew 34% to ₹19,415 million. The company commissioned four new hospitals during FY26 and has ambitious expansion plans with an estimated project cost of ₹8,300 crore.

Why This Matters

The strong financial performance indicates sustained demand and effective operational management across its business segments, including Healthcare Services, Apollo HealthCo, and AHLL. The planned expansion signals confidence in future growth, while the strategic move with Apollo HealthCo aims to unlock value and create a distinct entity for listing.

Strategic Moves and Future Plans

Apollo Hospitals has consistently focused on expanding its network and service offerings. The commissioning of new facilities and ongoing expansion projects are part of its long-term strategy to cater to India's growing healthcare needs. The company's board has approved a composite scheme for Apollo HealthCo, involving demerger and amalgamation, to create a new listed entity. This move is expected to streamline operations and create focused value propositions for different business verticals. The company is also undertaking significant expansion, adding beds and infrastructure.

Potential Hurdles

The proposed composite scheme for Apollo HealthCo requires shareholder and National Company Law Tribunal (NCLT) approval, which may involve procedural delays. Execution risks associated with large-scale expansion projects and integration of new facilities also need monitoring. Achieving projected revenue and EBITDA targets for FY27 will be key.

Market Context

While specific peer comparison data was not provided in the filing, Apollo Hospitals operates in a competitive healthcare market with players like Fortis Healthcare, Max Healthcare, and Narayana Health. Its recent performance suggests it is maintaining a strong market position, driven by its extensive network and diversified services.

Key Financials and Expansion Figures

• Consolidated Revenue Q4 FY26: ₹66,055 million (+18% YoY)
• Consolidated PAT Q4 FY26: ₹5,292 million (+36% YoY)
• Consolidated Revenue FY26: ₹252,285 million (+16% YoY)
• Consolidated PAT FY26: ₹19,415 million (+34% YoY)
• New Hospitals Commissioned FY26: 4
• Project Cost for Expansion: Approximately ₹8,300 crore

What to Watch Next

Investors will closely watch the shareholder meeting on June 24, 2026, for the Apollo HealthCo scheme approval. The anticipated listing of the new Apollo HealthCo entity by Q4 FY27 will be a key event. Company guidance for Q4 FY27 projects an annualized revenue run rate of ₹25,000 crore with EBITDA margins between 6.5% and 7.0%.